

        Trial Subjects

        Selection Criteria: Inclusion criteria:

        The subject must satisfy the following criteria for entry into the study:

          1. Male or female, aged 18 to 80 years.

          2. Provided informed consent prior to any study specific procedure being conducted.

          3. Virological or serological diagnosis of SARS-CoV-2.

          4. Evidence of viral pneumonia (either CT scan or Chest Ultrasonogram).

          5. Oxygen saturation at rest in ambient air <= 95%.

          6. PaO2/FiO2 <300mmHg without oxygen inhalation

          7. Fever defined as temperature >= 36.6*C armpit, >= 37.2*C oral, >= 37.8*C rectal.

        Exclusion criteria:

        The subject will be excluded from the study if any of the following applies:

          1. Subjects intubated prior to administration of IMP.

          2. Subjects requiring mechanical ventilation at screening.

          3. Known allergic reaction or intolerant to fish or fish oils.

          4. Known allergic reaction to excipients of IMP.

          5. Subjects who are pregnant or breast-feeding at screening.

          6. Subjects who are taking other fish-oil supplements (e.g. cod liver oil) who are
             unwilling to stop them for the duration of the study.

          7. Subjects taking warfarin or other anti-coagulants.

          8. Subjects who are taking other agents for the treatment of SARS-CoV-2 showing an
             improvement in symptoms in the 24 hours prior to study dosing.

          9. Subjects who are participating in other clinical studies at the same time.

         10. Evidence of multi-organ failure.

         11. Subjects with a do not resuscitate code.

         12. Subject is deemed, by the investigator, unlikely to be able to comply with the
             requirements of the protocol.
      